Federal award (PURCHASE ORDER, fiscal year 2023)
Recipient: ROCHE DIAGNOSTICS CORPORATION
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2022-10-01 to 2025-09-30
Current total value of award: $1449435.99
Description: CLINICAL CHEMISTRY AND IMMUNOASSAYS REAGENTS: MOD P00013 - EXERCISE OPTION II (1 OCT 2024 - 30 SEP 2025)